CSL Limited
CSL
Rang în acțiuni
#363
CSL Limited operates as a global biopharmaceutical company, engaged in the... CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
Preț acțiune
$138.58
Capitalizare de piață
$66.50B
Schimbare (1 zi)
0.72%
Schimbare (1 an)
-2.29%
Țară
AU
Tranzacționează CSL Limited (CSL)
Categorie
Healthcare
Istoricul spliturilor pentru CSL Limited (CSL)
Acțiunea CSL Limited (simbol: CSL) a trecut printr-un total de 1 splituri.
Cel mai recent split a avut loc pe Oct 18, 2007.
O acțiune CSL cumpărată înainte de Oct 18, 2007 este echivalentă astăzi cu 3 acțiuni CSL.
Cel mai recent split a avut loc pe Oct 18, 2007.
O acțiune CSL cumpărată înainte de Oct 18, 2007 este echivalentă astăzi cu 3 acțiuni CSL.
Listă splituri acțiuni
| An | Split | Multiplu | Multiplu cumulativ |
|---|---|---|---|
| 2007-10-18 | 3:1 | x3 | x3 |
Splituri pentru companii similare sau competitori
| Companie | Număr total de splituri | Multiplu cumulativ | Țara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
|
| 1 | x100 |
BE
|
